This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087057108314148v1 13/3/210    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lee, R. Articles by Liang, M. Search for Related Content PubMed PubMed Citation Articles by Lee, R. Articles by Liang, M. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

A High-Throughput Hybridoma Selection Method Using Fluorometric Microvolume Assay Technology

Astrazeneca Pharmaceuticals LP

^* To whom correspondence should be addressed. E-mail: meina.liang{at}astrazeneca.com.

	Abstract

Monoclonal antibodies (mAb) are not only useful reagents but also represent a promising type of therapeutics due to their high affinity and exquisite specificity for their antigens. A critical step in mAb generation is to identify antigen-specific antibodies. Although enzyme-linked immunosorbent assay (ELISA) has been broadly applied for antibody selection against secreted antigens, an inherent disadvantage for ELISA is the difficulty in identifying antibodies that recognize the native conformation of cell surface antigens. To overcome this drawback, the authors have developed a high-throughput cell-based antibody binding assay using fluorometric microvolume assay technology (FMAT). This method offers a homogeneous assay for detection of antibody binding to its antigen on the cell surface. To distinguish antibodies that bind to antigen on the cell surface from those that bind nonspecifically to cells, the binding is assessed using both antigen-expressing cells and related cells devoid of the antigen expression. This assay can detect antibodies at a concentration as low as 5 ng/mL and cell surface antigen as low as 9000 copies per cell. Results demonstrate that the FMAT method provides a sensitive and homogeneous assay to detect antibody binding to cell surface antigens and is amenable for high-throughput hybridoma selection. (Journal of Biomolecular Screening XXXX:xx-xx)

First published on February 29, 2008, doi:10.1177/1087057108314148

Journal of Biomolecular Screening 2008;13:210.

A more recent version of this article appeared on March 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Turunen, K. Takkinen, H. Soderlund, and T. Pulli Automated Panning and Screening Procedure on Microplates for Antibody Generation from Phage Display Libraries J Biomol Screen, March 1, 2009; 14(3): 282 - 293. [Abstract] [PDF]